Related Experiment Video
Updated: Aug 27, 2025
06:53
Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
Published on: September 9, 2020
2.9K
Systemic treatment for primary malignant sarcomas arising in craniofacial bones
1Pediatrics 5 (Oncology, Hematology, Immunology), Center for Pediatric, Adolescent and Women's Medicine, Stuttgart Cancer Center, Klinikum Stuttgart-Olgahospital, Stuttgart, Germany.
Frontiers in Oncology
|September 26, 2022
Summary
This review examines craniofacial bone sarcomas, highlighting that local control is key. Systemic chemotherapy effectiveness varies by tumor type, with specific indications for Ewing sarcoma and osteosarcoma.
Area of Science:
- Oncology
- Skeletal Biology
Background:
- Craniofacial bones are susceptible to various sarcomas.
- Understanding these malignancies is crucial for effective treatment.
Purpose of the Study:
- To review malignancies affecting the craniofacial region.
- To contextualize systemic treatment approaches for these rare tumors.
Main Methods:
- Non-systematic literature review.
Main Results:
- Common craniofacial bone sarcomas include osteosarcoma, Ewing sarcoma, and chondrosarcoma.
- Treatment strategies and tumor biology differ significantly.
- Local control is paramount for all craniofacial sarcomas.
- Chemotherapy efficacy varies: indicated for Ewing sarcoma, potentially beneficial for high-grade osteosarcoma and others, but not proven for all.
Conclusions:
- Diverse craniofacial sarcomas necessitate tailored treatment strategies.
- Local control remains the primary objective in managing these tumors.
- Further prospective trials are needed to refine systemic treatment protocols.
